Rights and permissions
About this article
Cite this article
Amfebutamone: risk associated with different tradename for new indication?. React. Wkly. 654, 3 (1997). https://doi.org/10.2165/00128415-199706540-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-199706540-00003